Immunogenicity risk assessment of peptide-related impurities identified in generic teriparatide products

12-2025

Establishment of Immune Biobank for Vaccine Immunogenicity Prediction Using In Vitro and In Silico Methods Against Porcine Reproductive and Respiratory Syndrome Virus

10-2025

POSTER: ISPRI, Interactive Screening and Protein Reengineering Interface for Complex Therapeutic Modalities

09-2025

A method for identifying neoantigens through isolation of circulating tumor cells using apheresis among patients with advanced-stage cancer

07-2025

T cell epitope content comparison using EpiCC correlates with vaccine efficacy against heterologous porcine reproductive and respiratory syndrome virus type 2 strains

06-2025

T-cell responses to highly conserved SARS-CoV-2 epitopes in Hispanic Americans receiving an mRNA COVID-19 vaccine

05-2025

POSTER: Enhancing Immunogenicity Risk Assessment: Leveraging ISPRI for Bispecific Antibody Analysis

04-2025

Regulatory T cell epitope content in human antibodies decreases during maturation

04-2025

Immunogenicity of Generic Peptide Impurities: Current Orthogonal Approaches

03-2025

Assessing the immunogenicity risk of salmon calcitonin peptide impurities using in silico and in vitro methods

08-2024

Poster: Immunogenicity Risk Assessment of Salmon Calcitonin Peptide Impurities Using In Silico and In Vitro Methods

05-2024

Poster: Rapid and Predictive Immunogenicity Risk Assessments Using In Silico Methods

05-2024